Replies to post #257641 on Anavex Life Sciences Corp (AVXL)

[XenaLives]

If (4) proves true the TGA could also decide that benefit was better than SOC and give provisional approval.

4. The precision medicine approach is now being tested in the current controlled trials to see if the data driven biomarker hypothesis can be confirmed
5. If (4) proves true, then the next trials will be precision medicine trials selecting patient enrollment on confirmed biomarkers